Cryo Cell International Income Statement (2010-2026) | CCEL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Aug2021	Nov2021	Feb2022	May2022	Aug2022	Nov2022	Feb2023	May2023	Aug2023	Nov2023	Feb2024	May2024	Aug2024	Nov2024	Feb2025	May2025	Aug2025	Nov2025	Feb2026	May2026
Revenue & cost
Revenue (Quarter)	7.50M	7.32M	7.26M	7.63M	7.68M	7.76M	7.82M	7.77M	7.87M	7.88M	7.85M	8.04M	8.07M	8.02M	7.97M	7.93M	7.83M	7.84M	7.68M	7.78M
Cost of Revenue (Quarter)	2.46M	2.30M	2.10M	2.20M	2.35M	2.14M	2.07M	2.14M	2.16M	2.02M	2.07M	2.02M	2.13M	1.64M	1.98M	1.86M	1.80M	1.73M	1.66M	1.68M
Gross Profit (Quarter)	5.04M	5.02M	5.16M	5.43M	5.33M	5.63M	5.76M	5.63M	5.71M	5.85M	5.79M	6.02M	5.94M	6.39M	5.98M	6.07M	6.02M	6.11M	6.03M	6.10M
Operating items
Research & Development (Quarter)	0.01M	0.03M	0.15M	0.08M	0.08M	0.08M	0.08M	0.30M	0.34M	0.44M	0.50M	0.24M	0.19M	0.30M	0.10M	0.13M	0.06M	0.08M	0.07M	0.10M
Selling, General & Administrative (Quarter)	3.49M	4.53M	3.38M	3.91M	3.60M	4.69M	3.88M	4.04M	3.80M	5.44M	4.43M	4.02M	4.16M	6.01M	4.64M	4.26M	3.88M	5.45M	5.01M	4.62M
Other Operating Expenses (Quarter)	2.40M	3.56M	2.26M	2.45M	3.04M	2.59M	2.18M	2.40M	2.56M	18.16M	2.10M	2.39M	2.32M	1.83M	2.18M	2.05M	1.99M	6.28M	1.84M	1.86M
Operating Expenses (Quarter)	5.91M	8.12M	5.79M	6.44M	6.73M	7.36M	6.14M	6.74M	6.71M	24.05M	7.03M	6.65M	6.68M	8.15M	6.91M	6.44M	5.92M	11.81M	6.92M	6.58M
Operating Income (Quarter)	1.60M	-0.81M	1.47M	1.19M	0.95M	0.41M	1.68M	1.03M	1.16M	-16.18M	0.82M	1.39M	1.39M	-0.12M	1.06M	1.49M	1.90M	-3.97M	0.77M	1.20M
EBIT (Quarter)	1.60M	-0.81M	1.47M	1.19M	0.95M	0.41M	1.68M	1.03M	1.16M	-16.18M	0.82M	1.39M	1.39M	-0.12M	1.06M	1.49M	1.90M	-3.97M	0.77M	1.20M
Non-operating items
Non Operating Investment Income (Quarter)	736.00	0.00M	-0.01M	-0.02M	-0.01M	-515.00	-0.00M	0.01M	0.09M	-0.05M	0.27M	0.26M	0.52M	0.02M	-0.03M	-0.38M	-0.19M	-0.20M	-0.24M	0.07M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	25.00	99.00	9.00		796.00	-0.06M	0.00M	-0.22M	0.28M	0.12M	63.00	0.15M		0.01M	0.00M	0.01M	0.02M		0.01M	338.00
Non Operating Income (Quarter)	-0.34M	-0.44M	-0.31M	-0.29M	-0.31M	0.22M	-0.47M	-0.68M	-0.09M	0.18M	-0.03M	0.08M	-0.01M	-0.72M	-0.52M	-0.92M	-0.71M	-0.67M	-0.69M	-0.37M
Net income details
EBT (Quarter)	1.26M	-1.24M	1.16M	0.90M	0.64M	0.62M	1.21M	0.35M	1.07M	-15.99M	0.79M	1.47M	1.38M	-0.84M	0.53M	0.58M	1.19M	-4.63M	0.07M	0.83M
Tax Provisions (Quarter)	0.40M	-0.96M	0.32M	0.27M	0.17M	-0.84M	0.45M	0.13M	0.39M	0.86M	0.24M	0.82M	0.33M	-1.14M	0.25M	0.22M	0.44M	-1.00M	0.02M	0.27M
Profit After Tax (Quarter)	0.86M	-0.64M	0.83M	0.63M	0.47M	0.84M	0.77M	0.22M	0.68M	-11.19M	0.56M	0.66M	1.05M	-1.86M	0.28M	0.36M	0.75M	-3.82M	0.05M	0.55M
Income from Continuing Operations (Quarter)	0.86M	-0.29M	0.83M	0.63M	0.47M	1.47M	0.77M	0.22M	0.68M	-16.85M	0.56M	0.66M	1.05M	0.30M	0.28M	0.36M	0.75M	-3.63M	0.05M	0.55M
Consolidated Net Income (Quarter)	0.86M	-0.29M	0.83M	0.63M	0.47M	1.47M	0.77M	0.22M	0.68M	-16.85M	0.56M	0.66M	1.05M	0.30M	0.28M	0.36M	0.75M	-3.63M	0.05M	0.55M
Income towards Parent Company (Quarter)	0.86M	-0.29M	0.83M	0.63M	0.47M	1.47M	0.77M	0.22M	0.68M	-16.85M	0.56M	0.66M	1.05M	0.30M	0.28M	0.36M	0.75M	-3.63M	0.05M	0.55M
Net Income towards Common Stockholders (Quarter)	0.86M	-0.29M	0.83M	0.63M	0.47M	1.47M	0.77M	0.22M	0.68M	-16.85M	0.56M	0.66M	1.05M	0.30M	0.28M	0.36M	0.75M	-3.63M	0.05M	0.55M
Additional items
EPS (Basic) (Quarter)	0.10	-0.04	0.10	0.08	0.06	0.17	0.09	0.03	0.08	-2.02	0.07	0.08	0.13	0.04	0.03	0.04	0.09	-0.45	0.01	0.07
EPS (Diluted) (Quarter)	0.10	-0.03	0.10	0.07	0.06	0.17	0.09	0.03	0.08	-2.02	0.07	0.08	0.13	0.04	0.03	0.04	0.09	-0.45	0.01	0.07
Shares Outstanding (Quarter)	8.45M	8.14M	8.53M	8.44M	8.39M	8.47M	8.47M	8.33M	8.29M	8.34M	8.28M	8.12M	8.06M	8.13M	8.08M	8.08M	8.06M	8.07M	8.06M	8.06M
Shares Outstanding (Diluted) (Quarter)	8.69M	8.36M	8.75M	8.55M	8.40M	8.48M	8.47M	8.33M	8.34M	8.34M	8.33M	8.23M	8.17M	8.21M	8.20M	8.13M	8.07M	8.07M	8.06M	8.06M
Shares Outstanding (Entity) (Quarter)	8.45M	8.14M	8.53M	8.44M	8.39M	8.47M	8.47M	8.33M	8.29M	8.34M	8.28M	8.12M	8.06M	8.13M	8.08M	8.08M	8.06M	8.07M	8.06M	8.06M
EBITDA (Quarter)	1.60M	-0.81M	1.47M	1.19M	0.95M	0.41M	1.68M	1.03M	1.16M	-16.18M	0.82M	1.39M	1.39M	-0.12M	1.06M	1.49M	1.90M	-3.97M	0.77M	1.20M
Interest Expenses (Quarter)	0.34M	-0.01M	0.31M	0.28M	0.37M	0.57M	0.47M	0.47M	1.41M	1.22M	0.44M	0.59M	0.53M	0.38M	0.49M	1.05M	3.20M	0.50M	1.60M	0.90M
Tax Rate (Quarter)	32.09%	77.07%	28.00%	29.46%	27.17%	-135.40%	36.86%	36.21%	36.25%	-5.38%	29.99%	55.45%	23.78%	135.73%	47.00%	38.14%	36.81%	21.56%	33.00%	33.00%

Research Tools

Datasets

Plans

Developers

Cryo Cell International Income Statement (2010-2026) | CCEL

Research Tools

Datasets

Plans

Developers

Cryo Cell International Income Statement (2010-2026) | CCEL

Create an account

Sign In

Reset Password